Literature DB >> 2903955

Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs.

K Hood1, D Gleeson, D C Ruppin, R H Dowling.   

Abstract

In laboratory animals, non-steroidal anti-inflammatory drugs (NSAIDs) are reported to inhibit diet-induced gallstone formation. To see if these drugs had a similar effect in man, 82 patients who had taken part in a comparison of ursodeoxycholic acid, placebo, and diet for prevention of gallstone recurrence were sent questionnaires about their use of NSAIDs during the period of the trial. 75 replied. After a mean follow-up of 33 (SEM 4) months none of the 12 regular users of NSAIDs had had gallstone recurrences, compared with 20 of the 63 who never or rarely used these drugs (p less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903955     DOI: 10.1016/s0140-6736(88)90812-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Extracorporeal biliary lithotripsy and direct chemolitholysis-an integrated concept.

Authors:  W Domschke
Journal:  Gastroenterol Jpn       Date:  1989-10

2.  Nonsteroidal anti-inflammatory drugs and gallstone formation.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 3.  Interactions between gall bladder bile and mucosa; relevance to gall stone formation.

Authors:  M R Jacyna
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

4.  Restraint urged for biliary lithotripsy.

Authors:  A L Flick
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

Review 5.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

6.  Cholelithiasic disease and associated factors in a Spanish population.

Authors:  F Devesa; J Ferrando; M Caldentey; A Borghol; M J Moreno; A Nolasco; J Moncho; J Berenguer
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

7.  Gallstone disease after extended (D2) lymph node dissection for gastric cancer.

Authors:  Tomotaka Akatsu; Masashi Yoshida; Tetsuro Kubota; Motohide Shimazu; Masakazu Ueda; Yoshihide Otani; Go Wakabayashi; Koichi Aiura; Minoru Tanabe; Toshiharu Furukawa; Yoshiro Saikawa; Shigeyuki Kawachi; Yukako Akatsu; Koichiro Kumai; Masaki Kitajima
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

8.  Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.

Authors:  A Das; S S Baijal; V A Saraswat
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

9.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?

Authors:  J J Donald; S Cheslyn-Curtis; A R Gillams; R C Russell; W R Lees
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.